After the treatment, the rats were fasted for 12 hours and euthanized by an overdose of pentobarbital sodium anesthesia (100 mg/kg i.p.)
Current Pharmaceutical Design (2011) Pentadecapeptide BPC 157 enhances the growth hormone recepto
: 3
10.1038/sj.bjp.0702879 35
As a class of drugs, GLP-1s have been shown to result in weight loss.[2] Common side effects of GLP-1s include nausea, vomiting, diarrhea, constipation, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, and gastroenteritis.[1-4] All GLP-1s carry a boxed warning for the risk of thyroid c-cell tumors and a contraindication for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2